Prostate Cancer
Treatment
Radiation therapy
The National Cancer Institute considers radiation therapy (also called radiotherapy) a viable option for men with any stage of prostate cancer. It may be used instead of surgery, or after surgery to destroy any cancer cells that may remain. Radiation also may be used to help relieve pain for men with late-stage prostate cancer.
Radiation therapy is a highly effective treatment that uses targeted high-energy rays to kill cancer cells. It is used to treat about 1 million cancer patients in the United States each year. Our state-of-the-art equipment enables RAS’ Radiation Oncologists to develop high-precision treatment plans that guard against damaging healthy tissues surrounding the tumor target. ROC dosimetrists and physicians meticulously calibrate the equipment to help minimize or avoid undesirable side effects that can include impotence, urinary incontinence and rectal bleeding. We offer prescribing physicians and their patients choice among several radiation therapy technologies.
Three-dimensional conformal radiation therapy (3-D CRT)
By means of a CT scan and computer mapping of each patient’s anatomy, 3-D CRT creates a three-dimensional image of the tumor. Guided by that map, ROC radiologists use a linear accelerator to concentrate the highest possible doses of radiation at the tumor site from four to six different directions, while sparing adjacent normal tissue as much as possible. Treatments lasting about 10 to 15 minutes per day are given five days a week over a duration of several weeks. Most men are able to continue their normal activities, including working and driving. Potential side effects may include fatigue, frequent urination, loose bowel movements, rectal irritation and diarrhea. Long-term complications are unlikely, but can occur. Your ROC radiation oncologist will discuss possible short-term and enduring effects.
Intensity-Modulated Radiation Therapy (IMRT)
IMRT is an advanced form of 3-D conformal radiation therapy that also delivers radiation externally from a linear accelerator. While 3-D CRT applies four to six radiation beams, IMRT targets the tumor with 60 to 70 beamlets of different intensities from numerous angles. This technology enables ROC to deliver of even higher doses of radiation to the prostate gland while minimizing exposure of the nearby bladder and rectum to radiation beams. Side effects and potential complications are similar to 3-D CRT, although they are less common and may be less pronounced.
Image-Guided Radiation Therapy (IGRT)
Image-guided radiation therapy incorporates CT, ultrasound, X-ray or other imaging techniques to help ROC radiologists guide the radiation beams during radiation therapy. The imagery can identify the precise location of the prostate, which ordinarily can shift by as much as an inch, depending on the fullness of the bladder and rectum. IGRT significantly improves the accuracy of radiation therapy and helps to reduce damage to healthy tissue.
ROC performs IGRT using three prostate localization methods:
The Calypso® 4D Localization System, which enables RAS’ radiation oncologists to pinpoint a prostate tumor’s location and continuously monitor its position throughout radiation treatment
- Placement of a special ultrasound probe on the outside of the abdomen to assist in targeting the prostate
- Injection of “marker” seeds in the prostate gland, imaged just before treatment using digital X-ray equipment.
Other methods
Additional methods available to treat prostate cancer must be performed at a hospital or other setting. They include:
Surgery. Radical prostatectomy – surgical removal of the prostate gland – can be performed either by the traditional “retropubic” method, requiring an incision, or by the da Vinci robotic method. Your urologist can discuss the benefits, recovery times and potential side effects of each approach.
Brachytherapy. Implantation of tiny radioactive seeds in the prostate is called brachytherapy. This procedure, performed in a hospital under anesthesia, involves permanent implantation of about 100 seeds. Brachytherapy may be performed alone or in combination with external beam radiation. The side effects and potential complications are similar to those seen with 3-D CRT.
High-dose rate temporary implant (HDR): This procedure, which also is performed in the hospital under anesthesia, involves temporary placement of radioactive material in 20 to 25 plastic tubes that are inserted into the prostate gland under ultrasound guidance. An HDR temporary implant requires an overnight hospital stay. After being discharged from the hospital, patients are given a reinforcing five-week outpatient course of external beam radiation therapy. The potential side effects and complications are similar to those of 3-D CRT.
Hormonal therapy: Prostate cancer usually is stimulated by the male hormone testosterone. Decreasing the amount of testosterone produced in the body or blocking its effects can kill some prostate cancer cells and also slow its overall growth. Hormonal therapy generally does not eliminate prostate cancer entirely by itself. It is sometimes used in combination with radiation therapy, especially for less favorable prostate cancers. It usually is administered in the form of a shot given every 1 to 4 months, and sometimes in pill form.
Proton therapy: Proton therapy is an external beam radiation approach that help spare the bladder and rectum from radiation exposure. It generally cannot use image guidance, and is available in only a few locations in the United States.
Cryotherapy: This surgical approach kills prostate tissue by freezing it with liquid nitrogen or liquid carbon dioxide. The surgeon inserts a probe through a small incision between the scrotum and anus. The method also is called cryoablation or cryosurgical ablation. Although cryotherapy is a promising approach, no conclusive long-term research studies have been completed yet to compare the results of cryotherapy to standard surgical or radiation approaches.
RAS Doctor Authors Study in New England Journal of Medicine - Windows Media Video
The Public File" with Kat Maudru Featuring Dr. Garrick Chang on Prostate Cancer - MP3 File
Learn More About SBRT for Prostate Cancer
Clinical Trials
Clinical trials, sponsored through the Radiation Therapy Oncology Group (RTOG) and the National Cancer Institute, may be available for you. By participating in a clinical trial, you may be able to receive newer types of treatment that might not otherwise be available. In addition, you will help other men in the future who face prostate cancer. You may ask your radiation oncologist if you are eligible.
Resources
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Morbi posuere odio interdum quam placerat egestas. Donec nec vehicula turpis. In convallis enim et nibh mattis in elementum lorem consequat. Donec eros odio, rhoncus in ultricies ut, hendrerit porta nisi. Sed sodales posuere neque eu aliquam. Vivamus ut orci ac nisl mollis elementum vel sed quam. Fusce tempor fringilla quam, quis pretium lectus hendrerit a. Donec ut ligula tellus, vel molestie elit. Fusce vestibulum massa ut nulla lobortis sollicitudin. Quisque faucibus ante ut elit cursus aliquam vel et massa. Integer tempor euismod purus, non gravida quam posuere et. Curabitur ut fermentum quam. Maecenas sit amet nisi diam. Vestibulum euismod nibh vitae turpis lobortis ut iaculis sem dignissim. Etiam quis ante tempus lorem auctor luctus vitae vitae nisl. Curabitur dictum mauris at erat malesuada interdum. Class aptent taciti sociosqu ad litora torquent per conubia nostra, per inceptos himenaeos. Integer luctus, ligula ac sodales rhoncus, lacus tellus porttitor dolor, eu condimentum arcu urna nec lectus. Lorem ipsum dolor sit amet, consectetur adipiscing elit. In hac habitasse platea dictumst.
Aenean ut libero turpis. Nulla justo purus, tempus nec gravida nec, sagittis vel mi. Vivamus erat est, porta vel pulvinar et, consectetur non sapien. In eget metus velit, at ornare augue. Quisque nibh sapien, molestie non blandit eget, porta id mauris. Nam tincidunt augue orci. Phasellus vestibulum viverra risus, at interdum nibh vulputate et. Aliquam rhoncus pretium sapien eu ullamcorper. Nunc sed suscipit tellus. Aliquam erat volutpat. Vestibulum consequat, tellus eget volutpat condimentum, turpis eros malesuada odio, sit amet blandit magna massa quis elit. Morbi tempor enim a leo elementum dapibus. Suspendisse magna risus, lacinia ac consequat nec, pretium vel dolor. Proin lacinia velit viverra mi convallis eget bibendum leo commodo.